The clinical relevance of PTENP1 is underscored by its frequent downregulation in gastric cancer, squamous cell carcinoma, and other malignancies, where reduced PTENP1 expression correlates with decreased PTEN levels and worse clinical outcomes [98, 99, 100, 101, 102]. The gene discussed is PTENP1; the disease is squamous cell carcinoma.